Globus Medical Launches AUTOBAHN® Intramedullary Nailing Platform at 2019 OTA Annual Meeting
September 24 2019 - 8:30AM
Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal
solutions company, today announced the launch of the AUTOBAHN®
Nailing System. This comprehensive platform provides advanced
clinical solutions for fractures of the tibia and femur.
The AUTOBAHN® portfolio includes the
Intramedullary Trochanteric Nail, Antegrade/Retrograde Femoral
Nail, and Tibial Nail. These new nail offerings are part of Globus
Medical’s expansion into the Trauma market over the past 24 months.
“Globus’ ability to understand our customers’ needs and to innovate
in this space allows us to provide instruments and solutions not
previously available to today’s surgeons,” says Barclay Davis, VP
of Trauma. The AUTOBAHN® Nailing System complements the available
ANTHEM® Plating and ARBOR® External Fixation Systems, and expands
the Globus Medical Trauma Portfolio.
- The AUTOBAHN®
Trochanteric Nailing System offers
treatment for trochanteric and femoral neck fractures. Three
different neck-shaft angles are available to accommodate varying
femoral neck anatomy. Streamlined instruments featuring dedicated
radiolucent aiming guides and unique fracture reduction forceps
offer system efficiency and provide improved visualization of the
femoral head. Radiographic markers embedded in the targeting arm
allow nail anteversion alignment for optimal placement.
- The
AUTOBAHN® Antegrade/Retrograde Femoral
Nailing System enables greater trochanter or piriformis
fossa surgical entry points. With the incorporation of
reconstruction (recon) holes and transverse options, this nail is
designed for more fracture patterns than any other nail on the
market. The A/R nailing system provides fixation for common femoral
shaft fractures as well as the benefit of recon holes and reverse
obliquity holes for fractures requiring more comprehensive
fixation. The addition of recon and reverse obliquity holes
distinguishes this system from its competition.
- The AUTOBAHN® Tibial
Nailing System includes instruments for the classic
infrapatellar approach and the novel suprapatellar approach that is
growing in clinical use. The system features novel headless locking
screws designed to decrease soft tissue irritation. SureStart™
threaded fixation is incorporated into the nail to facilitate
extreme nailing for stable fracture fixation. Instruments including
the one-piece Suprapatellar Cannula reduce the amount of procedural
steps.
To learn more about the AUTOBAHN® Nailing
Platform as well as the complete line of Globus Medical Trauma
products, visit booth #610 at OTA in Denver, Colorado September
26th-28th.www.globusmedical.com/trauma
About Globus Medical,
Inc.Globus Medical, Inc. is a leading musculoskeletal
solutions company based in Audubon, PA. The company was founded in
2003 by an experienced team of professionals with a shared vision
to create products that enable surgeons to promote healing in
patients with musculoskeletal disorders. Additional information can
be accessed at http://www.globusmedical.com.
Safe Harbor StatementsAll
statements included in this press release other than statements of
historical fact are forward-looking statements and may be
identified by their use of words such as “believe,” “may,” “might,”
“could,” “will,” “aim,” “estimate,” “continue,” “anticipate,”
“intend,” “expect,” “plan” and other similar terms. These
forward-looking statements are based on our current assumptions,
expectations and estimates of future events and trends.
Forward-looking statements are only predictions and are subject to
many risks, uncertainties and other factors that may affect our
businesses and operations and could cause actual results to differ
materially from those predicted. These risks and uncertainties
include, but are not limited to, factors affecting our quarterly
results, our ability to manage our growth, our ability to sustain
our profitability, demand for our products, our ability to compete
successfully (including without limitation our ability to convince
surgeons to use our products and our ability to attract and retain
sales and other personnel), our ability to rapidly develop and
introduce new products, our ability to develop and execute on
successful business strategies, our ability to comply with changing
laws and regulations that are applicable to our businesses, our
ability to safeguard our intellectual property, our success in
defending legal proceedings brought against us, trends in the
medical device industry, general economic conditions, and other
risks. For a discussion of these and other risks, uncertainties and
other factors that could affect our results, you should refer to
the disclosure contained in our most recent annual report on Form
10-K filed with the Securities and Exchange Commission, including
the sections labeled “Risk Factors” and “Cautionary Note Concerning
Forward-Looking Statements,” and in our Forms 10-Q, Forms 8-K and
other filings with the Securities and Exchange Commission. These
documents are available at www.sec.gov. Moreover, we operate in an
evolving environment. New risk factors and uncertainties emerge
from time to time and it is not possible for us to predict all risk
factors and uncertainties, nor can we assess the impact of all
factors on its business or the extent to which any factor, or
combination of factors, may cause actual results to differ
materially from those contained in any forward-looking statements.
Given these risks and uncertainties, readers are cautioned not to
place undue reliance on any forward-looking statements.
Forward-looking statements contained in this press release speak
only as of the date of this press release. We undertake no
obligation to update any forward-looking statements as a result of
new information, events or circumstances or other factors arising
or coming to our attention after the date hereof.
Contact:Brian KearnsSenior Vice
President, Business Development and Investor RelationsPhone: (610)
930-1800Email: investors@globusmedical.comwww.globusmedical.com
Globus Medical (NYSE:GMED)
Historical Stock Chart
From Mar 2024 to Apr 2024
Globus Medical (NYSE:GMED)
Historical Stock Chart
From Apr 2023 to Apr 2024